AIMM Therapeutics logo

AIMM Therapeutics

Crafting powerful antibody treatments sourced from the immune systems of recovered patients and immunized animals to combat cancer and infectious diseases.

est. 2004

VS
Alchemab Therapeutics Ltd logo

Alchemab Therapeutics Ltd

Pioneering Patient-led Antibody Therapeutics

71 employees · est. 2019 · London, United Kingdom

AIMM Therapeutics is the older company (2004 vs 2019).

Side-by-Side Comparison

AIMM Therapeutics Alchemab Therapeutics Ltd
Founded
2004 older 2019
Headquarters
Not tracked yet London, United Kingdom
Employees
Not tracked yet 71
Industry
Biotechnology Biotechnology, Pharmaceutical
Funding Stage
Series Unknown Series A
Total Funding
Not tracked yet $145.82M
Funding Rounds
1 8
Services
Not tracked yet Development of antibody therapeutics, Conducting clinical trials, Biopharmaceutical partnerships, Deep learning in drug development
Target Customers
Not tracked yet Healthcare providers, Pharmaceutical companies, Cancer research organizations, Biotech investors
Taxonomy
Antibody Treatments, Immune System, Recovered Patients, Cancer, Infectious Diseases, AIMM Therapeutics, Antibody-based Treatments, Effective Antibodies, Disease Treatment, Immunized Animals, Immunotherapy, Biotech Innovation, Medical Research, Drug Development, Therapeutic Antibodies Antibody Therapeutics, Patient-led Drug Discovery, Natural Protective Antibodies, Immunology, Hard-to-treat Diseases, Oncology Biotech, Neurodegenerative Diseases, Infectious Diseases, Biobank Collaboration, Function-first Approach, Innovative Drug Development, Biopharmaceutical Research, Collaborative Research, Biotech Disease Prevention
Website
aimmtherapeutics.com alchemab.com
AIMM Therapeutics logo

About AIMM Therapeutics

AIMM Therapeutics is a biotechnology startup founded in 2004, dedicated to crafting powerful antibody treatments for combatting cancer and infectious diseases. The company sources these treatments from the immune systems of recovered patients and immunized animals. AIMM Therapeutics develops antibod...

Alchemab Therapeutics Ltd logo

About Alchemab Therapeutics Ltd

Alchemab Therapeutics Ltd, founded in 2019 and headquartered in the United Kingdom, is at the forefront of harnessing the natural power of patient antibodies to tackle hard-to-treat diseases. Their slogan, "Pioneering Patient-led Antibody Therapeutics," encapsulates their innovative approach in the...

We will tell you when either one moves

BounceWatch watches AIMM Therapeutics and Alchemab Therapeutics Ltd for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at AIMM Therapeutics and Alchemab Therapeutics... — by email.

Frequently Asked Questions

AIMM Therapeutics — Crafting powerful antibody treatments sourced from the immune systems of recovered patients and immunized animals to combat cancer and infectious diseases.. Alchemab Therapeutics Ltd — Pioneering Patient-led Antibody Therapeutics . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
AIMM Therapeutics has raised undisclosed funding while Alchemab Therapeutics Ltd has raised $145.82M.
AIMM Therapeutics and Alchemab Therapeutics Ltd operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare AIMM Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AIMM Therapeutics on 26 Jul 2024, and Alchemab Therapeutics Ltd on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy